We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Urges Pa. Appeals Court To Undo $2.5M Risperdal Verdict

Law360 (August 8, 2018, 5:56 PM EDT) -- A Johnson & Johnson unit pushed a Pennsylvania appeals court on Wednesday to jettison a $2.5 million verdict on grounds that a trial judge improperly barred it from using a scientific article to challenge an expert’s opinion that the antipsychotic drug Risperdal caused an adolescent boy to grow breasts.

Robert Heim, an attorney with Dechert LLP representing J&J subsidiary Janssen Pharmaceuticals Inc., said the judge’s decision to bar the so-called learned treatise had allowed the expert’s opinion to go uncountered during cross-examination.

“Instead of being able...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.